Literature DB >> 1576391

Polypharmacy in psychiatry: three case studies and methods for prevention.

R B Stewart1, K C Yedinak, M R Ware.   

Abstract

OBJECTIVE: To illustrate problems of overprescribing in the elderly and to make practical suggestions for prevention of polypharmacy.
DESIGN: Three cases of polypharmacy in psychiatric patients admitted to the hospital between January and March 1990 are described. Intervention to correct drug-related problems in these patients is described and methods of preventing polypharmacy are discussed.
SETTING: Inpatient psychiatry service in a tertiary-care center. PATIENTS: Elderly psychiatry patients (n = 3) taking an excessive number of medications. This polypharmacy was believed to contribute to decreased cognitive and/or physical function.
INTERVENTIONS: Medication regimens were reviewed by the physician and pharmacist. Those considered unnecessary or believed to be adversely affecting the patient were discontinued.
RESULTS: All patients were discharged on a reduced number of medications, with improvement in cognitive and/or physical function.
CONCLUSIONS: Polypharmacy contributes to an increased incidence of adverse reactions in the elderly. Implementation of practical methods for reducing polypharmacy can lead to a reduction in the number of drug-related adverse effects and improved care of the elderly patient.

Entities:  

Mesh:

Year:  1992        PMID: 1576391     DOI: 10.1177/106002809202600415

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  5 in total

1.  Clinical significance of pharmacokinetic drug interactions with over-the-counter (OTC) drugs.

Authors:  P K Honig; B K Gillespie
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

Review 2.  Polypharmacy. Pharmacokinetic perspectives.

Authors:  P K Honig; L R Cantilena
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

Review 3.  Drug interactions between prescribed and over-the-counter medication.

Authors:  P K Honig; B K Gillespie
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

4.  Reasons for polypharmacy among psychiatric patients.

Authors:  Réka Viola; Katalin Csukonyi; Péter Doró; Zoltán Janka; Gyöngyvér Soós
Journal:  Pharm World Sci       Date:  2004-06

Review 5.  Polypharmacy in the aged. Practical solutions.

Authors:  R B Stewart; J W Cooper
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.